Related Experiment Videos
Atherosclerosis: an inflammatory disease
1Istituto di Cardiologia, e Fondazione per il Cuore, Università Cattolica del S. Cuore, Policlinico A. Gemelli, 8, 00168 Roma, Italy.
Insights
Systemic inflammation is crucial in atherosclerosis and acute coronary syndromes. Inflammatory markers like C-reactive protein can predict prognosis in some patients, guiding future research.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathophysiology
Background:
- Inflammation is central to atherosclerosis development and acute vascular events.
- Systemic inflammatory signs are often present in unstable angina and myocardial infarction.
- Acute inflammatory reactions can independently determine prognosis in acute ischemic syndromes.
Purpose of the Study:
- To investigate the role of systemic inflammation in acute coronary syndromes.
- To assess the clinical value of inflammatory markers in disease activity and prognosis.
- To identify factors contributing to the progression of aggressive acute coronary syndromes.
Main Methods:
- Analysis of systemic inflammatory markers, including C-reactive protein.
- Evaluation of short- and long-term prognostic value of inflammation.
- Observational study of patients with acute ischemic syndromes.
Main Results:
- Systemic inflammation is detectable in many patients with acute ischemic syndromes.
- C-reactive protein shows clinical value in assessing disease activity and prognosis.
- Acute inflammatory reactions appear to be independent prognostic determinants in a subset of patients.
Conclusions:
- Systemic inflammation is a significant factor in acute coronary syndromes.
- Inflammatory markers are valuable for prognosis assessment.
- Further research is needed to understand the mechanisms driving aggressive acute coronary syndromes.
Abstract:
Inflammation plays a pivotal role in both the development of atherosclerosis and the acute activation of the vascular wall with consequent local thrombosis and vasoconstriction (with or without plaque fissure). In many patients with unstable angina and acute myocardial infarction, systemic signs of inflammation are detectable. The use of systemic inflammatory markers, such as C-reactive protein as marker of disease activity and short- and long-term prognosis, seems to be of clinical value. Therefore, acute inflammatory reaction, detectable systematically, appears to be an independent determinant of prognosis in some patients with acute ischemic syndromes, but is not detectable in all. Understanding the causes of inflammation and the additional elusive components that result in the progression to aggressive acute coronary syndromes, is the future goal of cardiology.